Now showing items 21-24 of 24

    • Gill, Dipender; Georgakis, Marios K.; Koskeridis, Fotios; Jiang, Lan; Feng, Qiping; Wei, Wei-Qi; Theodoratou, Evropi; Elliott, Paul; Denny, Joshua C.; Malik, Rainer; Evangelou, Evangelos; Dehghan, Abbas; Dichgans, Martin; Tzoulaki, Ioanna (Circulation, 2019-07-23)
      Background: Drug effects can be investigated through natural variation in the genes for their protein targets. The present study aimed to use this approach to explore the potential side effects and repurposing potential ...
    • Lindenfeld, Joann (European Journal of Heart Failure, 2019-07)
      Aims Heart failure ( HF) is associated with considerable symptom burden and impairment in physical functioning and quality of life. The sodium-glucose co-transporter 2 inhibitor empagliflozin reduced the risk of HF ...
    • Nickel, Nils P.; Fessel, Joshua P.; Cogan, Joy D.; Hamid, Rizwam; West, James D.; de Caestecker, Mark P.; Austin, Eric D. (PULMONARY CIRCULATION, 2019-06)
      Low-grade albuminuria, determined by the urinary albumin to creatinine ratio, has been linked to systemic vascular dysfunction and is associated with cardiovascular mortality. Pulmonary arterial hypertension is related to ...
    • Crossley, George H.; Padeletti, Luigi; Zweibel, Steven; Hudnall, Harrison; Zhang, Yan; Boriani, Giuseppe (PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2019-07)
      Background Reactive atrial-based antitachycardia pacing (rATP) aims to terminate atrial tachyarrhythmia/atrial fibrillation (AT/AF) episodes when they spontaneously organize to atrial flutter or atrial tachycardia; however, ...